South Africa’s antitrust regulator wants Roche penalised for ‘excessive’ cancer drug pricing

Stat News

9 February 2022 - South Africa’s anti-trust regulator has recommended that Roche should be penalised for allegedly “excessive” pricing of its Herceptin breast cancer treatment, arguing it violates basic human rights by impeding access to a life saving medicine.

Read Stat News article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Cancer , Medicine , Pricing , South Africa